A new tool could reduce costs for diagnosing infectious diseases.
Dupilumab Proves Effective in Chronic Spontaneous Urticaria
BOSTON — Add-on dupilumab (Dupixent) significantly reduced itching and urticaria in patients with chronic spontaneous urticaria (CSU) whose symptoms were uncontrolled with H1-antihistamine therapy. The